Diagnostic Potential of Exosomal and Non-Exosomal Biomarkers in Lung Cancer: A Comparative Analysis Using a Rat Model of Lung Carcinogenesis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Exosomal microRNAs (miRNAs) show high efficacy for early lung cancer detection. These biomarkers in exosomes offer improved diagnostic performance compared to serum during tumor development.
Area Of Science
- Biomarker Discovery
- Cancer Diagnostics
- Molecular Biology
Background
- Liquid biopsy biomarkers are crucial for effective cancer diagnosis.
- Exosomal cargo (miRNAs, proteins) is more stable in biofluids than free forms.
- Direct comparisons of exosomal vs. non-exosomal biomarker diagnostic performance are limited.
Purpose Of The Study
- To evaluate and compare the diagnostic value of selected miRNAs and protein markers.
- To assess biomarkers in exosomal versus non-exosomal fractions.
- To analyze biomarker performance across different stages of lung carcinogenesis in a rat model.
Main Methods
- Induced lung cancer in rats, collecting blood and tissue samples.
- Investigated expression of miR-19b, miR-21, miR-145 in exosomes, serum, and tissue.
- Quantified exosomal and serum levels of CEA and CYFRA 21-1.
Main Results
- Exosomal miRNA expression dynamically changed with tumor induction, showing high diagnostic efficacy.
- Exosomal miR-19b and miR-21 were upregulated early; serum/tissue forms increased late.
- Serum CYFRA 21-1 outperformed its exosomal counterpart; CEA increased in both fractions.
Conclusions
- Exosomal biomarkers hold significant value for liquid biopsies.
- Integrating exosomal biomarkers can enhance early lung cancer detection.
- Exosomal biomarkers aid in monitoring lung cancer development.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.